Ahn-Gook Pharmaceutical Co., Ltd.

A001540

KR7001540004

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
7,520 ^KRW	+0.67%		-0.27%	-20.09%

16/05	Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
20/03	Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2020.

September 23, 2022 at 09:07 am IST

From April 1, 2022 to June 30, 2022, the company has repurchased 48,924 shares, representing 0.43% for KRW 554 million. With this, the company has completed the repurchase of 93,781 shares, representing 0.82% for KRW 989.14 million under the buyback announced on March 27, 2020.

Latest news about Ahn-Gook Pharmaceutical Co., Ltd.

Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05	CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03	CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11	CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	22/23/22	CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2020.	23/22/23	CI
Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2020.	23/22/23	CI
Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2020.	23/22/23	CI
Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2020.	23/22/23	CI
Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2020.	23/22/23	CI
Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback announced on March 27, 2020 has expired with 93,781 shares, representing 0.82% for KRW 989.14 million.	23/22/23	CI
Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on December 26, 2002.	24/22/24	CI
Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback announced on December 26, 2002, has expired with 1,145,246 shares, representing 97.65% for KRW 2,441.63 million.	24/22/24	CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/22/16	CI
Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till September 23, 2022.	25/22/25	CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	21/22/21	CI
Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback announced on January 8, 2021, has expired.	07/22/07	CI
Ahn-Gook Pharmaceutical Co. Ltd.'s Equity Buyback Plan Extended till June 24, 2022.	24/21/24	CI
Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback announced on December 26, 2002, has expired.	24/21/24	CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/21/15	CI
Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback announced on March 27, 2020, has expired.	25/21/25	CI
Ahn-Gook Pharmaceutical Co. Ltd.'s Equity Buyback Plan Extended till June 24, 2021.	24/21/24	CI
Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till September 25, 2021.	25/21/25	CI

Chart Ahn-Gook Pharmaceutical Co., Ltd.

Duration

Period

More charts

Company Profile

AHN-GOOK PHARMACEUTICAL Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. It also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The Company distributes its product within domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
AHN-GOOK PHARMACEUTICAL CO., LTD.	-20.09%	6.18Cr
SUN PHARMACEUTICAL INDUSTRIES LTD.	+15.91%	4.2TCr
OTSUKA HOLDINGS CO., LTD.	+22.40%	2.23TCr
SANDOZ GROUP AG	+18.48%	1.52TCr
CIPLA LIMITED	+16.12%	1.4TCr
ZYDUS LIFESCIENCES LIMITED	+45.12%	1.21TCr
ONO PHARMACEUTICAL CO., LTD.	-9.58%	679.6Cr
THE MEDICINES COMPANY	-0.05%	678.76Cr
STADA ARZNEIMITTEL	-8.87%	572.55Cr
ASPEN PHARMACARE HOLDINGS LIMITED	+14.18%	549.33Cr